|
CA2668417A1
(en)
*
|
2006-11-03 |
2008-05-15 |
Alphavax, Inc. |
Alphavirus and alphavirus replicon particle formulations and methods
|
|
US20090111099A1
(en)
*
|
2007-10-27 |
2009-04-30 |
Yongsheng Ma |
Promoter Detection and Analysis
|
|
US8067241B2
(en)
*
|
2009-08-26 |
2011-11-29 |
General Electric Company |
Method and apparatus for antigen retrieval process
|
|
DK2529020T3
(en)
*
|
2010-01-28 |
2018-08-06 |
Childrens Hospital Philadelphia |
SCALABLE PREPARATION PLATF FOR CLEANING VIRAL VECTORS AND CLEANED VIRAL VECTORS FOR USE IN GENTHERAPY
|
|
KR101549296B1
(ko)
|
2010-04-14 |
2015-09-01 |
이엠디 밀리포어 코포레이션 |
고역가 고순도 바이러스 스톡의 생산 방법 및 이의 사용 방법
|
|
CA2829774C
(en)
*
|
2011-03-14 |
2019-09-24 |
National Research Council Of Canada |
Method of viral production in cells
|
|
EP2782596A4
(en)
|
2011-11-22 |
2015-07-29 |
Philadelphia Children Hospital |
VIRAL VECTORS FOR HIGHLY EFFECTIVE TRANSGEN DELIVERY
|
|
US20140349403A1
(en)
|
2011-12-12 |
2014-11-27 |
The Children's Hospital Of Philadelphia |
Large commercial scale lentiviral vector production system and vectors produced thereby
|
|
DK3010537T3
(en)
*
|
2013-06-17 |
2018-09-24 |
De Staat Der Nederlanden Vert Door De Mini Van Vws Mini Van Volksgezondheit Welzijn En Sport |
PROCEDURE FOR PREVENTING AGGREGATION OF VIRUS COMPONENTS
|
|
US10161011B2
(en)
|
2013-11-29 |
2018-12-25 |
Takara Bio Inc. |
Method for quantifying adeno-associated virus
|
|
JP6730193B2
(ja)
|
2014-04-25 |
2020-07-29 |
ジェネトン |
高ビリルビン血症の処置
|
|
US10577627B2
(en)
|
2014-06-09 |
2020-03-03 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
WO2016004319A1
(en)
*
|
2014-07-02 |
2016-01-07 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for purifying recombinant adeno-associated virus
|
|
SG10202007103TA
(en)
|
2014-11-05 |
2020-09-29 |
Voyager Therapeutics Inc |
Aadc polynucleotides for the treatment of parkinson's disease
|
|
CA2975583A1
(en)
|
2014-11-14 |
2016-05-19 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
US10597660B2
(en)
|
2014-11-14 |
2020-03-24 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
|
WO2016094783A1
(en)
|
2014-12-12 |
2016-06-16 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scaav
|
|
WO2016114992A2
(en)
|
2015-01-13 |
2016-07-21 |
Alfa Wassermann, Inc. |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) and gradients and flow-through buffers therefore
|
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
WO2017075335A1
(en)
|
2015-10-28 |
2017-05-04 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
EP3387117B1
(en)
*
|
2015-12-11 |
2022-11-23 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for aav8
|
|
HUE061100T2
(hu)
|
2016-03-28 |
2023-05-28 |
Ultragenyx Pharmaceutical Inc |
Adenovírus hõinaktiválásának módszerei
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
WO2017189964A2
(en)
|
2016-04-29 |
2017-11-02 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
CA3024448A1
(en)
|
2016-05-18 |
2017-11-23 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
EP3458589A4
(en)
|
2016-05-18 |
2020-01-01 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
|
|
DK3488007T3
(da)
*
|
2016-07-21 |
2024-02-19 |
Spark Therapeutics Inc |
Skalerbare fremgangsmåder med høj indvinding til fremstilling af højt udbytte rekombinant adeno-associeret viral (raav) vektor og rekombinante adeno-associeret virale (raav) vektorer produceret derved
|
|
EP4219724A3
(en)
|
2016-08-23 |
2023-09-27 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
JP2019531787A
(ja)
|
2016-08-30 |
2019-11-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
生物医学的ターゲティング及びデリバリーの方法並びにそれを実行するための装置及びシステム
|
|
EP3293260A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
EP3293259A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
EP3293203A1
(en)
|
2016-09-12 |
2018-03-14 |
Genethon |
Acid-alpha glucosidase variants and uses thereof
|
|
MX2019002842A
(es)
|
2016-09-12 |
2019-08-29 |
Genethon |
Variantes de alfa-glucosidasa acida y usos de las mismas.
|
|
CN109952372A
(zh)
|
2016-09-16 |
2019-06-28 |
白血球保健股份有限公司 |
获得有效用于疫苗接种或基因治疗的基于病毒载体的组合物的新方法
|
|
RU2769196C2
(ru)
*
|
2016-11-04 |
2022-03-29 |
Такеда Фармасьютикал Компани Лимитед |
Составы с аденоассоциированным вирусом
|
|
US10626376B2
(en)
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
|
US10294452B2
(en)
*
|
2016-11-22 |
2019-05-21 |
Dao-Yao He |
Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
|
|
US11357735B2
(en)
|
2017-02-01 |
2022-06-14 |
Centre National De La Recherche Scientifique |
Particles and compositions comprising the same for transfection
|
|
CA3053455A1
(en)
|
2017-03-10 |
2018-09-13 |
Genethon |
Treatment of glycogen storage disease iii
|
|
AU2018261790A1
(en)
|
2017-05-05 |
2019-11-28 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (ALS)
|
|
CA3061368A1
(en)
|
2017-05-05 |
2018-11-08 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating huntington's disease
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
US11497576B2
(en)
|
2017-07-17 |
2022-11-15 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
CA3071978A1
(en)
|
2017-08-03 |
2019-02-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3697908A1
(en)
|
2017-10-16 |
2020-08-26 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
EP3697905A1
(en)
|
2017-10-16 |
2020-08-26 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
BR112019013268A2
(pt)
*
|
2017-11-08 |
2019-12-17 |
Avexis Inc |
meios e métodos para a preparação de vetores virais e usos dos mesmos
|
|
WO2019113202A1
(en)
*
|
2017-12-05 |
2019-06-13 |
Applied Genetic Technologies Corporation |
Formulation optimization for viral particles
|
|
US20210346519A1
(en)
|
2018-02-07 |
2021-11-11 |
Genethon |
Hybrid regulatory elements
|
|
US20210010028A1
(en)
|
2018-03-06 |
2021-01-14 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
|
AU2019257755A1
(en)
|
2018-04-27 |
2020-11-12 |
Voyager Therapeutics, Inc. |
Methods for measuring the potency of AADC viral vectors
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
US20210214749A1
(en)
|
2018-05-16 |
2021-07-15 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
JP2021529001A
(ja)
|
2018-06-29 |
2021-10-28 |
ウーハン ニューロフス バイオテクノロジー リミテッド カンパニーＷｕｈａｎ Ｎｅｕｒｏｐｈｔｈ Ｂｉｏｔｅｃｈｎｏｌｏｇｙ Ｌｉｍｉｔｅｄ Ｃｏｍｐａｎｙ |
レーベル遺伝性視神経症を治療するための組成物及び方法
|
|
JP2021529513A
(ja)
|
2018-07-02 |
2021-11-04 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
筋萎縮性側索硬化症および脊髄に関連する障害の治療
|
|
SG11202012946RA
(en)
*
|
2018-07-11 |
2021-02-25 |
Baxalta Inc |
Aav compositions
|
|
WO2020023612A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
PT3833746T
(pt)
|
2018-08-08 |
2023-05-25 |
Inst Nat Sante Rech Med |
Mini-gde para o tratamento de doença de armazenamento de glicogénio iii
|
|
KR20210068014A
(ko)
|
2018-08-20 |
2021-06-08 |
우한 뉴로프스 바이오테크놀로지 리미티드 컴퍼니 |
레버 유전성 시신경병증의 치료를 위한 조성물 및 방법
|
|
US20210348242A1
(en)
|
2018-10-04 |
2021-11-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
JP2022522995A
(ja)
|
2019-01-18 |
2022-04-21 |
ボイジャー セラピューティクス インコーポレイテッド |
Ａａｖ粒子を生成するための方法及びシステム
|
|
CA3130525A1
(en)
|
2019-04-08 |
2020-10-15 |
Giuseppe RONZITTI |
Hybrid promoters for muscle expression
|
|
JP2022529002A
(ja)
|
2019-04-19 |
2022-06-16 |
レジェンクスバイオ インコーポレーテッド |
アデノ随伴ウイルスベクター製剤及び方法
|
|
CN113692411A
(zh)
|
2019-04-19 |
2021-11-23 |
吉尼松公司 |
成纤维细胞生长因子23相关的低磷酸盐血症的基因治疗
|
|
US20220243225A1
(en)
|
2019-04-29 |
2022-08-04 |
Voyager Therapeutics, Inc. |
SYSTEMS AND METHODS FOR PRODUCING BACULOVIRAL INFECTED INSECT CELLS (BIICs) IN BIOREACTORS
|
|
CN114174514A
(zh)
|
2019-07-25 |
2022-03-11 |
诺华股份有限公司 |
可调节的表达系统
|
|
US20220290182A1
(en)
|
2019-08-09 |
2022-09-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
WO2021028559A1
(en)
|
2019-08-14 |
2021-02-18 |
Leukocare Ag |
Method for obtaining efficient compositions comprising viral vectors for vaccination or gene therapy
|
|
US11155835B2
(en)
*
|
2019-08-19 |
2021-10-26 |
The Catholic University Of America |
Prokaryotic-eukaryotic hybrid viral vector for delivery of large cargos of genes and proteins into human cells
|
|
WO2021041485A1
(en)
|
2019-08-26 |
2021-03-04 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2021071835A1
(en)
|
2019-10-07 |
2021-04-15 |
Regenxbio Inc. |
Adeno-associated virus vector pharmaceutical composition and methods
|
|
CA3151442A1
(en)
|
2019-10-22 |
2021-04-29 |
Pasqualina COLELLA |
Sortilin receptor ligand based chimeric polypeptides and uses thereof
|
|
WO2021078834A1
(en)
|
2019-10-22 |
2021-04-29 |
Genethon |
Chimeric acid-alpha glucosidase polypeptides and uses thereof
|
|
CN113025633A
(zh)
|
2019-12-09 |
2021-06-25 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
|
KR102167829B1
(ko)
*
|
2020-02-10 |
2020-10-20 |
주식회사 이노테라피 |
아데노연관바이러스용 안정화제 및 이를 이용한 아데노연관바이러스의 안정화 방법
|
|
CA3168055A1
(en)
|
2020-02-21 |
2021-08-26 |
Emmanuel John Simons |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
WO2021236908A2
(en)
|
2020-05-20 |
2021-11-25 |
Biomarin Pharmaceutical Inc. |
Use of regulatory proteins for the production of adeno-associated virus
|
|
EP3913060A1
(en)
|
2020-05-22 |
2021-11-24 |
Genethon |
Vectors encoding a glucose-6-phosphatase (g6pase-a) for gene therapy
|
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
EP4200410A1
(en)
|
2020-08-24 |
2023-06-28 |
Genethon |
C-terminal truncated gde for the treatment of glycogen storage disease iii
|
|
CN116635530A
(zh)
|
2020-11-02 |
2023-08-22 |
生物马林药物股份有限公司 |
用于富集腺相关病毒的方法
|
|
US20240067942A1
(en)
|
2020-12-09 |
2024-02-29 |
Genethon |
Lysosomal acid lipase variants and uses thereof
|
|
WO2022187548A1
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4301768A2
(en)
|
2021-03-03 |
2024-01-10 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
EP4333896A1
(en)
*
|
2021-05-07 |
2024-03-13 |
Board of Regents, The University of Texas System |
Methods and compositions for transport, storage, and delivery of adeno-associated viral vector and other molecules
|
|
CA3226119A1
(en)
|
2021-08-04 |
2023-02-09 |
Giuseppe RONZITTI |
Hybrid promoters for gene expression in muscles and in the cns
|
|
CN117980484A
(zh)
|
2021-09-16 |
2024-05-03 |
诺华股份有限公司 |
新颖的转录因子
|
|
WO2023073526A1
(en)
|
2021-10-25 |
2023-05-04 |
Novartis Ag |
Methods for improving adeno-associated virus (aav) delivery
|
|
WO2023175584A1
(en)
|
2022-03-17 |
2023-09-21 |
Innoskel |
Polynucleotides encoding the alpha-1 chain of human type ii collagen and methods of their use
|
|
WO2023175585A1
(en)
|
2022-03-17 |
2023-09-21 |
Innoskel |
Hybrid promoters and their use in osteolysis syndrome
|
|
WO2023214346A1
(en)
|
2022-05-06 |
2023-11-09 |
Novartis Ag |
Novel recombinant aav vp2 fusion polypeptides
|
|
WO2023237731A1
(en)
|
2022-06-09 |
2023-12-14 |
Genethon |
N-terminal truncated gde for the treatment of glycogen storage disease iii
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|